An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
This blood test is 100% accurate in identifying a hard-to-diagnose cardiac disease
The first sign of Brugada syndrome is often sudden death
COVID-19 Research Funding Opportunity
Addressing a pressing need in health research
New study: protein REEP5 plays critical role in the heart
New study: protein REEP5 plays critical role in the heart
Ted Rogers Centre for Heart Research celebrates fifth anniversary
The promise of a record gift is coming to fruition
Education Fund has now supported 68 trainees with $1.4 million
Announcing 11 winners of our 5th competition
First ECHO Pitch 2019 competition a huge success, unanimous winner takes $250,000 in startup funding
At ECHO PITCH 2019, one startup earned $250K in funding
Our 2019 Innovation Fund awards: 3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
Three bold projects target special challenges in HF
World-first technology to clear the heart of dangerous protein deposits
‘Desperate need for therapies for AL amyloid cardiomyopathy’
Confronting one of the world’s greatest health challenges
Collaborative Ted Rogers Centre has taken new aim at heart failure
Ted Rogers Centre launches four years ago today
Marking the largest gift in Canadian health-care history